Attitude and Practice towards Pre-exposure Prophylaxis (PrEP) for HIV Prevention among Female Sex Workers in Kicukiro District, Rwanda

Alice  Umulisa; Dr Yves  Urayeneza; Viateur Hategekimana

doi:10.53639/ijssr.v5i3.276

Authors

Alice Umulisa Mount Kenya University, Kigali
Dr Yves Urayeneza Catholic University of Rwanda
Viateur Hategekimana University of Rwanda

DOI:

https://doi.org/10.53639/ijssr.v5i3.276

Keywords:

Attitude, Practice, HIV Pre-exposure Prophylaxis, Female sex workers, Kicukiro district

Abstract

This study aimed to assess the attitude, and Practice of female sex workers towards Pre-exposure Prophylaxis for HIV prevention in the Kicukiro district, Rwanda. The study used a descriptive cross-sectional design, using a probability sampling method, and the Yamane formula was used to calculate the sample size of 300 female sex workers including a 10% non-response rate. Primary data was collected using a structured questionnaire, at 10 health centers. Analysis was conducted using IBM SPSS software, with chi-square tests and logistic regression for inferential analysis. The ethical clearance was acquired from the Mount Kenya University ethics committee and the Young Women Christian Association Rwanda. The study findings showed that (60%) of female sex workers have a positive attitude towards PrEP, and 60.4% of respondents were using PrEP. Demographic factors like age group, marital status, and Ubudehe category were significantly associated with practices. Female sex workers aged between 25 and 29 had 4 times more chance to have good practices. This study provides insights into improving PrEP education and interventions targeting female sex workers and other key populations. These findings highlighted the concerns about stigma and privacy, and the need for public health interventions that target it in the community.

Downloads

Download data is not yet available.

References

Auerbach, J. D., Kinsky, S., Brown, G., & Charles, V. (2015). Knowledge, Attitudes, and Likelihood of Pre-Exposure Prophylaxis (PrEP) Use Among US Women at Risk of Acquiring HIV. AIDS Patient Care and STDs, 29(2), 102–110. https://doi.org/10.1089/apc.2014.0142

CDC. (2022, Juli 5). Pre-Exposure Prophylaxis (PrEP) | HIV Risk and Prevention | HIV/AIDS | CDC. Https://Www.Cdc.Gov/Hiv/Risk/Prep/Index.Html. https://www.cdc.gov/hiv/risk/prep/index.html

Daniels, J., De Vos, L., Bezuidenhout, D., Atujuna, M., Celum, C., Hosek, S., Bekker, L.-G., & Medina-Marino, A. (2023). “I know why I am taking this pill”: Young women navigation of disclosure and support for PrEP uptake and adherence in Eastern Cape Province, South Africa. PLOS Global Public Health, 3(1), e0000636. https://doi.org/10.1371/journal.pgph.0000636

Faini, D., Munseri, P., Sandstrom, E., Hanson, C., & Bakari, M. (2023). Awareness, Willingness and Use of HIV Pre-Exposure Prophylaxis Among Female Sex Workers Living in Dar-es-Salaam, Tanzania. AIDS and Behavior, 27(1), 335–343. https://doi.org/10.1007/s10461-022-03769-4

Foley, S., Keene, D. E., Shrestha, R., Brown, S.-E., Gautam, K., Sutherland, R., Maviglia, F., Saifi, R., & Wickersham, J. A. (2024). Exploring Attitudes Toward Pre-Exposure Prophylaxis for HIV Prevention Prior to Implementation Among Female Sex Workers in Malaysia: Results from a Qualitative Study. Patient Preference and Adherence, Volume 18, 797–807. https://doi.org/10.2147/PPA.S413423

Golin, R., Godfrey, C., Firth, J., Lee, L., Minior, T., Phelps, B. R., Raizes, E. G., Ake, J. A., & Siberry, G. K. (2020). PEPFAR’s response to the convergence of the HIV and COVID‐19 pandemics in Sub‐Saharan Africa. Journal of the International AIDS Society, 23(8), e25587. https://doi.org/10.1002/jia2.25587

Jaspal, R., & Daramilas, C. (2016). Perceptions of pre-exposure prophylaxis (PrEP) among HIV-negative and HIV-positive men who have sex with men (MSM). Cogent Medicine, 3(1), 1256850. https://doi.org/10.1080/2331205X.2016.1256850

Kambutse, I., Igiraneza, G., & Ogbuagu, O. (2018). Perceptions of HIV transmission and pre-exposure prophylaxis among health care workers and community members in Rwanda. PLoS ONE, 13(11), e0207650. https://doi.org/10.1371/journal.pone.0207650

Kate Segal. (2021). African nations lead the world in offering PrEP HIV prevention drug. AVAC. https://www.newscientist.com/article/2266273-african-nations-lead-the-world-in-offering-prep-hiv-prevention-drug/

Makhakhe, N. F., Sliep, Y., & Meyer-Weitz, A. (2022). “Whatever is in the ARVs, is Also in the PrEP” Challenges Associated With Oral Pre-exposure Prophylaxis Use Among Female Sex Workers in South Africa. Frontiers in Public Health, 10. https://www.frontiersin.org/articles/10.3389/fpubh.2022.691729

Manguro, G. O., Musau, A. M., Were, D. K., Tengah, S., Wakhutu, B., Reed, J., Plotkin, M., Luchters, S., Gichangi, P., & Temmerman, M. (2022). Increased condom use among key populations using oral PrEP in Kenya: Results from large scale programmatic surveillance. BMC Public Health, 22. https://doi.org/10.1186/s12889-022-12639-6

Mutagoma, M., Samuel, M. S., Kayitesi, C., Gasasira, A. R., Chitou, B., Boer, K., Hedt-Gauthier, B., Gupta, N., Ntaganira, J., & Nsanzimana, S. (2017). High HIV prevalence and associated risk factors among female sex workers in Rwanda. International Journal of STD & AIDS, 28(11), 1082–1089. https://doi.org/10.1177/0956462416688137

Nsanzimana, S., Mills, E. J., Harari, O., Mugwaneza, P., Karita, E., Uwizihiwe, J. P., Park, J. J., Dron, L., Condo, J., Bucher, H., & Thorlund, K. (2020). Prevalence and incidence of HIV among female sex workers and their clients: Modelling the potential effects of intervention in Rwanda. BMJ Global Health, 5(8), e002300. https://doi.org/10.1136/bmjgh-2020-002300

Nsanzimana, S., Rwibasira, G. N., Malamba, S. S., Musengimana, G., Kayirangwa, E., Jonnalagadda, S., Fazito Rezende, E., Eaton, J. W., Mugisha, V., Remera, E., Muhamed, S., Mulindabigwi, A., Omolo, J., Weisner, L., Moore, C., Patel, H., & Justman, J. E. (2022a). HIV incidence and prevalence among adults aged 15-64 years in Rwanda: Results from the Rwanda Population-based HIV Impact Assessment (RPHIA) and District-level Modeling, 2019. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases, 116, 245–254. https://doi.org/10.1016/j.ijid.2022.01.032

Nsanzimana, S., Rwibasira, G. N., Malamba, S. S., Musengimana, G., Kayirangwa, E., Jonnalagadda, S., Fazito Rezende, E., Eaton, J. W., Mugisha, V., Remera, E., Muhamed, S., Mulindabigwi, A., Omolo, J., Weisner, L., Moore, C., Patel, H., & Justman, J. E. (2022b). HIV incidence and prevalence among adults aged 15-64 years in Rwanda: Results from the Rwanda Population-based HIV Impact Assessment (RPHIA) and District-level Modeling, 2019. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases, 116, 245–254. https://doi.org/10.1016/j.ijid.2022.01.032

PrEPwatch. (2023, Mei). Rwanda PrEP initiation. PrEPWatch. https://www.prepwatch.org/countries/rwanda/

Rwanda-National-HIV-Guidelines-for-Prevention-Management-of-HIV-2020.pdf. (t.t.). Diambil 20 Mei 2023, dari https://www.prepwatch.org/wp-content/uploads/2022/08/Rwanda-National-HIV-Guidelines-for-Prevention-Management-of-HIV-2020.pdf

Stewart, J., & Baeten, J. M. (2022). HIV pre-exposure prophylaxis and sexually transmitted infections: Intersection and opportunity. Nature reviews. Urology, 19(1), 7–15. https://doi.org/10.1038/s41585-021-00527-4

Sundareshan, V., Swinkels, H. M., Nguyen, A. D., Mangat, R., & Koirala, J. (2024). Preexposure Prophylaxis for HIV Prevention. Dalam StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK507789/

Terefe, B., Jembere, M. M., Asgedom, D. K., & Lakew, A. M. (2024). Knowledge and attitude to HIV pre exposure prophylaxis among women in five sub-Saharan African countries: A multilevel model analysis of population-based survey 2021–2022. BMC Public Health, 24(1), 1253. https://doi.org/10.1186/s12889-024-18717-1

The 2019-20 Rwanda Demographic and Health Survey (RDHS) | National Institute of Statistics Rwanda. (2019, 2020). https://www.statistics.gov.rw/publication/1724

Thomson, K. A., Baeten, J. M., Mugo, N. R., Bekker, L.-G., Celum, C. L., & Heffron, R. (2020). Tenofovir-based Oral PrEP Prevents HIV Infection among Women. Current Opinion in HIV and AIDS, 11(1), 18. https://doi.org/10.1097/COH.0000000000000207

Vail, R. M., Fine, S. M., McGowan, J. P., Merrick, S. T., Radix, A., Rodrigues, J., Hoffmann, C. J., Stevens, L. C., & Gonzalez, C. J. (2022). PrEP to Prevent HIV and Promote Sexual Health. Johns Hopkins University. http://www.ncbi.nlm.nih.gov/books/NBK556471/

WHO. (2021). Global data shows increasing PrEP use and widespread adoption of WHO PrEP recommendations. Https://Www.Who.Int/News-Room/Feature-Stories/Detail/Global-Data-Shows-Increasing-Prep-Use-and-Widespread-Adoption-of-Who-Prep-Recommendations. https://www.who.int/news-room/feature-stories/detail/global-data-shows-increasing-prep-use-and-widespread-adoption-of-who-prep-recommendations

WHO-CDS-HIV-18.10-eng.pdf. (t.t.). Diambil 1 Februari 2023, dari https://apps.who.int/iris/bitstream/handle/10665/279834/WHO-CDS-HIV-18.10-eng.pdf